These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 7509121

  • 1. Response to sotalol predicts the response to amiodarone during serial drug testing in patients with sustained ventricular tachycardia and coronary artery disease.
    Martínez-Rubio A, Shenasa M, Chen X, Wichter T, Breithardt G, Borggrefe M.
    Am J Cardiol; 1994 Feb 15; 73(5):357-60. PubMed ID: 7509121
    [Abstract] [Full Text] [Related]

  • 2. Electrophysiologic effects of sotalol and amiodarone in patients with sustained monomorphic ventricular tachycardia.
    Man KC, Williamson BD, Niebauer M, Daoud E, Bakr O, Strickberger SA, Hummel JD, Kou W, Morady F.
    Am J Cardiol; 1994 Dec 01; 74(11):1119-23. PubMed ID: 7977070
    [Abstract] [Full Text] [Related]

  • 3. Frequency dependent effects of d-sotalol and amiodarone on the action potential duration of the human right ventricle.
    Huikuri HV, Yli-Mäyry S.
    Pacing Clin Electrophysiol; 1992 Nov 01; 15(11 Pt 2):2103-7. PubMed ID: 1279607
    [Abstract] [Full Text] [Related]

  • 4. Electrophysiologic mechanisms of antiarrhythmic efficacy of a sotalol and class Ia drug combination: elimination of reverse use dependence.
    Lee SD, Newman D, Ham M, Dorian P.
    J Am Coll Cardiol; 1997 Jan 01; 29(1):100-5. PubMed ID: 8996301
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I, Saksena S, Krol RB, Munsif AN, Kolettis T, Mathew P, Varanasi S, Prakash A, Delfaut P, Lewis CB.
    Am J Cardiol; 1997 Sep 11; 80(5B):3F-9F. PubMed ID: 9291444
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Usefulness of sotalol in suppressing ventricular tachycardia or ventricular fibrillation in patients with healed myocardial infarcts.
    Kuchar DL, Garan H, Venditti FJ, Finkelstein D, Rottman JN, McComb J, McGovern BA, Ruskin JN.
    Am J Cardiol; 1989 Jul 01; 64(1):33-6. PubMed ID: 2741811
    [Abstract] [Full Text] [Related]

  • 11. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS, Fineberg N, Heger JJ, Miles WM, Kammerling JM, Chang MS, Zipes DP, Prystowsky EN.
    Am J Cardiol; 1988 May 01; 61(13):1024-30. PubMed ID: 3364357
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and electrophysiologic effects of oral sotalol in patients with sustained ventricular tachycardia caused by coronary artery disease.
    Kus T, Campa MA, Nadeau R, Dubuc M, Kaltenbrunner W, Shenasa M.
    Am Heart J; 1992 Jan 01; 123(1):82-9. PubMed ID: 1729853
    [Abstract] [Full Text] [Related]

  • 13. Results of late programmed electrical stimulation and long-term electrophysiologic effects of amiodarone therapy in patients with refractory ventricular tachycardia.
    Veltri EP, Reid PR, Platia EV, Griffith LS.
    Am J Cardiol; 1985 Feb 01; 55(4):375-9. PubMed ID: 3969872
    [Abstract] [Full Text] [Related]

  • 14. Prospective clinical evaluation and follow-up of a cohort of consecutive VT/VF patients, using a staged-care protocol, including coronary arteriography, programmed electrical stimulation and cardiac surgery.
    Naccarella F, Rolli A, Carboni A, Finardi A, Aurier E, Favaro L, Contini S, Gherli T, Caponi D, Maranga SS, Lepera G, Bartoletti A.
    G Ital Cardiol; 1999 Oct 01; 29(10):1142-56. PubMed ID: 10546124
    [Abstract] [Full Text] [Related]

  • 15. Clinical usefulness of electrophysiologic testing in patients with ventricular tachycardia and chronic chagasic cardiomyopathy treated with amiodarone or sotalol.
    Leite LR, Fenelon G, Simoes A, Silva GG, Friedman PA, de Paola AA.
    J Cardiovasc Electrophysiol; 2003 Jun 01; 14(6):567-73. PubMed ID: 12875414
    [Abstract] [Full Text] [Related]

  • 16. Beneficial effect of amiodarone on pacing induced terminability of reentrant ventricular tachycardia.
    Chinushi M, Uchiyama H, Nakagawa I, Washizuka T, Aizawa Y.
    Jpn Heart J; 1999 Jul 01; 40(4):471-5. PubMed ID: 10611912
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A prospective study of the efficacy and safety of adjuvant metoprolol and xamoterol in combination with amiodarone for resistant ventricular tachycardia associated with impaired left ventricular function.
    Bashir Y, Paul VE, Griffith MJ, Sneddon JF, Farrell TG, Ward DE, Camm AJ.
    Am Heart J; 1992 Nov 01; 124(5):1233-40. PubMed ID: 1442491
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
    Haverkamp W, Martinez-Rubio A, Hief C, Lammers A, Mühlenkamp S, Wichter T, Breithardt G, Borggrefe M.
    J Am Coll Cardiol; 1997 Aug 01; 30(2):487-95. PubMed ID: 9247523
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.